Exchange: NASDAQ·Updated 07:30 PM EDT

TRAX First Tracks Biotherapeutics Inc.

$40.46
$2.05
(4.82%)
Today
Closed $40.46
$0.00
(0.00%)
After Hours
Mkt Cap$1.45B
Vol456,232.00

About TRAX

First Tracks Biotherapeutics, Inc. engages in the research and development of immunology therapeutics for autoimmune and inflammatory diseases. It focuses on clinical-stage programs for rosnilimab, ANB033 and ANB101. The company is headquartered in San Diego, CA.
56

Bullish Sentiment

How do you feel about TRAX?

Advertisement|Remove ads.